Literature DB >> 19768380

Carbapenem-resistant Acinetobacter baumannii producing the OXA-23 enzyme: dissemination in Southern Brazil.

A F Martins, R Kuchenbecker, T Sukiennik, R Boff, K C Reiter, L Lutz, A B M P Machado, A L Barth.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19768380     DOI： 10.1007/s15010-009-9003-9

Source DB:  PubMed          Journal:  Infection        ISSN： 0300-8126            Impact factor:   3.553


× No keyword cloud information.
  13 in total

1.  Dissemination of Acinetobacter baumannii clones with OXA-23 Carbapenemase in Colombian hospitals.

Authors:  Maria Virginia Villegas; Juan Nicolas Kattan; Adriana Correa; Karen Lolans; Ana Maria Guzman; Neil Woodford; David Livermore; John P Quinn
Journal:  Antimicrob Agents Chemother       Date:  2007-04-02       Impact factor: 5.191

2.  Characterization of genetic diversity of carbapenem-resistant Acinetobacter baumannii clinical strains collected from 2004 to 2007.

Authors:  Chao Qi; Michael Malczynski; Michelle Parker; Marc H Scheetz
Journal:  J Clin Microbiol       Date:  2008-01-23       Impact factor: 5.948

Review 3.  How to select and interpret molecular strain typing methods for epidemiological studies of bacterial infections: a review for healthcare epidemiologists. Molecular Typing Working Group of the Society for Healthcare Epidemiology of America.

Authors:  F C Tenover; R D Arbeit; R V Goering
Journal:  Infect Control Hosp Epidemiol       Date:  1997-06       Impact factor: 3.254

Review 4.  Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology.

Authors:  L Poirel; P Nordmann
Journal:  Clin Microbiol Infect       Date:  2006-09       Impact factor: 8.067

5.  Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp.

Authors:  Neil Woodford; Matthew J Ellington; Juliana M Coelho; Jane F Turton; M Elaina Ward; Susan Brown; Sebastian G B Amyes; David M Livermore
Journal:  Int J Antimicrob Agents       Date:  2006-03-24       Impact factor: 5.283

6.  Characterization of a nosocomial outbreak caused by a multiresistant Acinetobacter baumannii strain with a carbapenem-hydrolyzing enzyme: high-level carbapenem resistance in A. baumannii is not due solely to the presence of beta-lactamases.

Authors:  G Bou; G Cerveró; M A Domínguez; C Quereda; J Martínez-Beltrán
Journal:  J Clin Microbiol       Date:  2000-09       Impact factor: 5.948

7.  Occurrence of carbapenem-resistant Acinetobacter baumannii clones at multiple hospitals in London and Southeast England.

Authors:  Juliana M Coelho; Jane F Turton; Mary E Kaufmann; Judith Glover; Neil Woodford; Marina Warner; Marie-France Palepou; Rachel Pike; Tyrone L Pitt; Bharat C Patel; David M Livermore
Journal:  J Clin Microbiol       Date:  2006-10       Impact factor: 5.948

8.  Outbreak of carbapenem-resistant Acinetobacter baumannii producing the OXA-23 enzyme in Curitiba, Brazil.

Authors:  Libera M Dalla-Costa; Juliana M Coelho; Helena A P H M Souza; Maria E S Castro; Christiane J N Stier; Karin L Bragagnolo; Alvaro Rea-Neto; Sergio R Penteado-Filho; David M Livermore; Neil Woodford
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

9.  Risk factors for nosocomial imipenem-resistant Acinetobacter baumannii infections.

Authors:  Gülseren Baran; Ayse Erbay; Hürrem Bodur; Pinar Ongürü; Esragül Akinci; Neriman Balaban; Mustafa A Cevik
Journal:  Int J Infect Dis       Date:  2007-05-21       Impact factor: 3.623

Review 10.  Current control and treatment of multidrug-resistant Acinetobacter baumannii infections.

Authors:  Drosos E Karageorgopoulos; Matthew E Falagas
Journal:  Lancet Infect Dis       Date:  2008-12       Impact factor: 25.071
View more
  12 in total

1.  Clinical characteristics and outcomes of bacteremia due to different genomic species of Acinetobacter baumannii complex in patients with solid tumors.

Authors:  M-C Chiang; S-C Kuo; S-J Chen; S-P Yang; Y-T Lee; T-L Chen; C-P Fung
Journal:  Infection       Date:  2011-09-02       Impact factor: 3.553

2.  Control of an Acinetobacter [corrected] baumannii outbreak in a neonatal ICU without suspension of service: a devastating outbreak in Diyarbakir, Turkey.

Authors:  S Hosoglu; M Hascuhadar; E Yasar; S Uslu; B Aldudak
Journal:  Infection       Date:  2011-09-01       Impact factor: 3.553

3.  Low prevalence of blaOXA-143 in private hospitals in Brazil.

Authors:  Jéssica S Werneck; Renata C Picão; Raquel Girardello; Rodrigo Cayô; Vitor Marguti; Líbera Dalla-Costa; Ana C Gales; Charline S Antonio; Patrícia R Neves; Micheli Medeiros; Elsa M Mamizuka; Maria R Elmor de Araújo; Nilton Lincopan
Journal:  Antimicrob Agents Chemother       Date:  2011-09       Impact factor: 5.191

4.  Resistance traits and molecular characterization of multidrug-resistant Acinetobacter baumannii isolates from an intensive care unit of a tertiary hospital in Guangdong, southern China.

Authors:  Zhuo-Ran Chen; Hui-Wu Guo; Jun Liu; Qing Pan; Mao-Zhang Fu; Ying-Kun Qiu; Nai-Kei Wong; Yuan-Chun Huang
Journal:  Int Microbiol       Date:  2022-01-31       Impact factor: 3.097

5.  The inhibitory effect of Zingiber corallinum Hance essential oil on drug-resistant bacteria and evaluation of its acute toxicity.

Authors:  Ce Yang; Lin-Lin Zhou; Hai-Yan Wang; Su-Na Huang; Qing Liu; Shi-Lin Hu; Ting-Rong Li; Yan-Bing Chen; Jian-Xin Jiang
Journal:  Med Sci Monit       Date:  2011-05

6.  Association of blaOXA-23 and bap with the persistence of Acinetobacter baumannii within a major healthcare system.

Authors:  Ting L Luo; Alexander H Rickard; Usha Srinivasan; Keith S Kaye; Betsy Foxman
Journal:  Front Microbiol       Date:  2015-03-12       Impact factor: 5.640

7.  Acinetobacter baumannii strains isolated from patients in intensive care units in Goiânia, Brazil: Molecular and drug susceptibility profiles.

Authors:  Suellen Rocha Araújo Castilho; Cássia Silva de Miranda Godoy; Adriana Oliveira Guilarde; Juliana Lamaro Cardoso; Maria Cláudia Porfirio André; Ana Paula Junqueira-Kipnis; André Kipnis
Journal:  PLoS One       Date:  2017-05-05       Impact factor: 3.240

8.  Molecular characterization and clonal dynamics of nosocomial blaOXA-23 producing XDR Acinetobacter baumannii.

Authors:  Sabrina Royer; Paola Amaral de Campos; Bruna Fuga Araújo; Melina Lorraine Ferreira; Iara Rossi Gonçalves; Deivid William da Fonseca Batistão; Rebecca Tavares E Silva Brígido; Louise Teixeira Cerdeira; Luiz Gustavo Machado; Cristiane Silveira de Brito; Paulo Pinto Gontijo-Filho; Rosineide Marques Ribas
Journal:  PLoS One       Date:  2018-06-11       Impact factor: 3.240

9.  First occurrence of bla OXA-58 in Acinetobacter baumannii isolated from a clinical sample in Southern Brazil.

Authors:  Carolina de Souza Gusatti; Lauren Martins Bertholdo; Letícia Muner Otton; Desirée Padilha Marchetti; Alessandra Einsfeld Ferreira; Gertrudes Corção
Journal:  Braz J Microbiol       Date:  2012-06-01       Impact factor: 2.476

10.  Molecular identification of Acinetobacter baumannii isolated from intensive care units and their antimicrobial resistance patterns.

Authors:  Hasan Ghajavand; Bahram Nasr Esfahani; Seyed Asghar Havaei; Sharareh Moghim; Hossein Fazeli
Journal:  Adv Biomed Res       Date:  2015-05-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.